(NASDAQ: HURA) Tuhura Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.61%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.32%.
Tuhura Biosciences's earnings in 2025 is -$27,303,032.On average, 2 Wall Street analysts forecast HURA's earnings for 2025 to be -$25,989,836, with the lowest HURA earnings forecast at -$27,518,649, and the highest HURA earnings forecast at -$24,461,022. On average, 2 Wall Street analysts forecast HURA's earnings for 2026 to be -$25,553,032, with the lowest HURA earnings forecast at -$28,392,257, and the highest HURA earnings forecast at -$22,713,806.
In 2027, HURA is forecast to generate -$27,955,453 in earnings, with the lowest earnings forecast at -$27,955,453 and the highest earnings forecast at -$27,955,453.